Try our Advanced Search for more refined results
December 14, 2011
Cephalon, Inc. et al v. Celgene Corp. et al
Case Number:
1:11-cv-12226
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 19, 2015
Acusphere Fights Celgene's Bid For Atty Fees In Patent Row
Specialty pharmaceutical company Acusphere Inc. fought back Tuesday against Celgene Corp.'s bid for attorneys' fees in a patent dispute over anti-tumor drug Abraxane, telling a Massachusetts federal court there was nothing frivolous about its case.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login